No Data
Hong Kong Stock Exchange Announcement | Bank of Zhengzhou intends to sell assets held by Zhongyuan Assets for 10 billion yuan.
Zhiyun Health (09955) has obtained the exclusive rights in China for the importation, distribution, sales, and promotion of Livemin and Shibao Litong tablets in hospitals and pharmacies for five years.
UBTECH ROBOTICS Moves Toward Full Share Circulation
UBTECH ROBOTICS Plans Share Conversion and Listing
It is recommended to apply for full circulation of H shares for UBOX (09880.HK).
Guangguan News, September 2nd, Youmi Selection (09880.HK) announced that, in light of the guidelines, the board of directors has reviewed and approved the proposal for the full circulation of H shares on September 2, 2024. Upon obtaining all relevant approvals (including the filing notice issued by the China Securities Regulatory Commission and the approval of the Hong Kong Stock Exchange) and complying with all applicable laws, rules, and regulations, 35,201,371 domestic shares will be converted into H shares, and the company will apply to the Hong Kong Stock Exchange for the listing and trading of such H shares on the main board of the Hong Kong Stock Exchange.
A quick look at UBTECH (09880)'s mid-term performance in 2024.
In the first half of 2024, U-Btech achieved a revenue of 0.487 billion yuan, a year-on-year increase of 86.6%; a gross profit of 0.185 billion yuan, a year-on-year increase of 213.9%, with a gross margin of 38%.
UBTECH's revenue increased, narrowing the proportion of losses. The training time for humanoid robots may be over one year. | Interpretations
①UBTECH's income increased significantly in the first half of 2024, and the proportion of losses narrowed. ②Regarding the market's attention to the progress of humanoid robot product training, UBTECH told reporters that it may take 12 months to 18 months from training to market entry. ③In a recent discussion, Boston Dynamics founder Marc Raibert expressed different views on the commercialization of humanoid robots.
No Data
